These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 1845900

  • 1. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
    Zimber-Strobl U, Suentzenich KO, Laux G, Eick D, Cordier M, Calender A, Billaud M, Lenoir GM, Bornkamm GW.
    J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
    [Abstract] [Full Text] [Related]

  • 2. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M, Calender A, Billaud M, Zimber U, Rousselet G, Pavlish O, Banchereau J, Tursz T, Bornkamm G, Lenoir GM.
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [Abstract] [Full Text] [Related]

  • 3. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
    Murray RJ, Young LS, Calender A, Gregory CD, Rowe M, Lenoir GM, Rickinson AB.
    J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E.
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [Abstract] [Full Text] [Related]

  • 5. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    Zimber-Strobl U, Kremmer E, Grässer F, Marschall G, Laux G, Bornkamm GW.
    EMBO J; 1993 Jan; 12(1):167-75. PubMed ID: 8381349
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context.
    Cordier-Bussat M, Billaud M, Calender A, Lenoir GM.
    Int J Cancer; 1993 Jan 02; 53(1):153-60. PubMed ID: 8416201
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    Laux G, Dugrillon F, Eckert C, Adam B, Zimber-Strobl U, Bornkamm GW.
    J Virol; 1994 Nov 02; 68(11):6947-58. PubMed ID: 7933076
    [Abstract] [Full Text] [Related]

  • 9. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
    Billaud M, Rousset F, Calender A, Cordier M, Aubry JP, Laisse V, Lenoir GM.
    Blood; 1990 May 01; 75(9):1827-33. PubMed ID: 1691936
    [Abstract] [Full Text] [Related]

  • 10. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.
    Strobl LJ, Höfelmayr H, Marschall G, Brielmeier M, Bornkamm GW, Zimber-Strobl U.
    J Virol; 2000 Feb 01; 74(4):1727-35. PubMed ID: 10644343
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD, Rowe M, Cadwallader K, Ricksten A, Gordon J, Wang F, Rymo L, Rickinson AB.
    J Virol; 1990 May 01; 64(5):2126-34. PubMed ID: 2157875
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation.
    Gahn TA, Sugden B.
    J Virol; 1993 Nov 01; 67(11):6379-86. PubMed ID: 8411339
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.
    J Virol; 1993 May 01; 67(5):2853-61. PubMed ID: 8386279
    [Abstract] [Full Text] [Related]

  • 17. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M, Lundgren E.
    Oncogene; 1992 Sep 01; 7(9):1775-82. PubMed ID: 1354347
    [Abstract] [Full Text] [Related]

  • 18. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
    Knutson JC.
    J Virol; 1990 Jun 01; 64(6):2530-6. PubMed ID: 2159528
    [Abstract] [Full Text] [Related]

  • 19. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB.
    J Virol; 1992 Dec 01; 66(12):7461-8. PubMed ID: 1331531
    [Abstract] [Full Text] [Related]

  • 20. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
    Schlager S, Speck SH, Woisetschläger M.
    J Virol; 1996 Jun 01; 70(6):3561-70. PubMed ID: 8648690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.